Drug Shortage Report for FOQUEST
| Report ID | 151791 |
| Drug Identification Number | 02470357 |
| Brand name | FOQUEST |
| Common or Proper name | methylphenidate hydrochloride Controlled Release Capsules |
| Company Name | ELVIUM LIFE SCIENCES |
| Market Status | MARKETED |
| Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE (CONTROLLED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 60 |
| ATC code | N06BA |
| ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2022-01-07 |
| Actual start date | 2022-01-05 |
| Estimated end date | 2024-08-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-03-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v75 | 2023-02-02 | French | Compare |
| v74 | 2023-02-02 | English | Compare |
| v73 | 2023-01-26 | French | Compare |
| v72 | 2023-01-26 | English | Compare |
| v71 | 2023-01-20 | French | Compare |
| v70 | 2023-01-20 | English | Compare |
| v69 | 2023-01-13 | French | Compare |
| v68 | 2023-01-13 | English | Compare |
| v67 | 2023-01-09 | French | Compare |
| v66 | 2023-01-09 | English | Compare |
| v65 | 2022-12-21 | French | Compare |
| v64 | 2022-12-21 | English | Compare |
| v63 | 2022-12-15 | French | Compare |
| v62 | 2022-12-15 | English | Compare |
| v61 | 2022-12-09 | French | Compare |
| v60 | 2022-12-09 | English | Compare |
| v59 | 2022-12-02 | French | Compare |
| v58 | 2022-12-02 | English | Compare |
| v57 | 2022-11-28 | French | Compare |
| v56 | 2022-11-28 | English | Compare |